ijms-logo

Journal Browser

Journal Browser

Gonadotropin Cell Transduction Mechanisms

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Macromolecules".

Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 30008

Special Issue Editors


E-Mail Website
Guest Editor
Faculty of Bioscience and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo, Italy
Interests: cell biology; biology of stem cells; biology of reproduction; ovarian angiogenesis; signal transduction; molecular biology; tissue regeneration; regenerative medicine; cancer; histology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biosciences and Technology for Food, Agriculture and Environment, University of Teramo, 64100 Teramo, Italy
Interests: cell biology; biology of amniotic derived stem cells; tissue regeneration; regenerative medicine; biology of reproduction; ovarian angiogenesis; signal transduction; molecular biology; advanced reproductive biotechnology techniques
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Faculty of Biosciences and Agro-Food and Environmental Technologies, University of Teramo, 64100 Teramo, Italy
Interests: cell biology; biology of amniotic derived stem cells; biology of reproduction; ovarian angiogenesis; signal transduction; histology; tissue regeneration; regenerative medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues

Gonadotropins act in concert in the regulation of the female and male reproductive systems. Through intricate endocrine communication routes, paracrine and autocrine communication along the HPG axis, they sustain the production of sex steroids by gonads. Different signaling cascades and transcriptional mechanisms are activated, depending on the variation in GnRH pulse frequency, after the synthesis and release of FSH and LH, whose biological effects are mediated directly by coupled receptors (FSHR and LHCGR) or indirectly through different mediators. The orchestrated signaling activation promotes different biological responses, such as ovarian angiogenesis, folliculogenesis, oocyte selection, fertilization and pregnancy, as well as testicular development and spermatogenesis. Moreover, gonadotropins are intertwined in a network of interactions with other hormones, which all contribute to the functioning of the reproductive system. The dysregulation of one or more of the transduction mechanisms evolves in reproductive disorders, such as infertility and cancer. Despite recent progress in understanding the mechanisms and signaling mediated by gonadotropins, their complex pathways in cells remain to be fully elucidated. The increasing new techniques applied in all fields of biotechnology and the in vitro and in vivo study of reproductive cells, as well as new sources of stem cells, could help to clarify most of the unknown signaling mediated by gonadotropins, opening up new perspectives in the comprehension of physiological and pathological events in the biology of reproduction.

Contributions to this Special Issue, of both original research articles and topical reviews, will provide new insights into the mechanisms of action of gonadotropins, deepen our understanding of their biological roles in health and disease, and reveal novel therapeutic opportunities in reproductive and regenerative medicine.

Prof. Dr. Annunziata Mauro
Prof. Dr. Barbara Barboni
Prof. Dr. Paolo Berardinelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gonadotropins
  • GnRH
  • signal transduction
  • reproduction
  • fertility
  • testis
  • ovary
  • spermatogenesis
  • ovogenesis
  • gametes
  • stem cells
  • sex steroids

Related Special Issue

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

4 pages, 198 KiB  
Editorial
Gonadotropin Cell Transduction Mechanisms
by Annunziata Mauro, Paolo Berardinelli and Barbara Barboni
Int. J. Mol. Sci. 2022, 23(11), 6303; https://doi.org/10.3390/ijms23116303 - 04 Jun 2022
Cited by 2 | Viewed by 1263
Abstract
The intention of this Special Edition was to collect review and original research articles that illustrate and stimulate the growing efforts to highlight the mechanisms of action of gonadotropins, as well as deepen our understanding of their biological roles in health and disease, [...] Read more.
The intention of this Special Edition was to collect review and original research articles that illustrate and stimulate the growing efforts to highlight the mechanisms of action of gonadotropins, as well as deepen our understanding of their biological roles in health and disease, aiming at revealing novel therapeutic opportunities in reproductive and regenerative medicine [...] Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)

Research

Jump to: Editorial, Review

18 pages, 3368 KiB  
Article
Effects of P4 Antagonist RU486 on VEGF and Its Receptors’ Signaling during the In Vivo Transition from the Preovulatory to Periovulatory Phase of Ovarian Follicles
by Annunziata Mauro, Paolo Berardinelli, Valentina Russo, Nicola Bernabò, Alessandra Martelli, Delia Nardinocchi, Oriana Di Giacinto, Maura Turriani and Barbara Barboni
Int. J. Mol. Sci. 2021, 22(24), 13520; https://doi.org/10.3390/ijms222413520 - 16 Dec 2021
Cited by 2 | Viewed by 2256
Abstract
The development of an adequate blood vessel network is crucial for the accomplishment of ovarian follicle growth and ovulation, which is necessary to support the proliferative and endocrine functions of the follicular cells. Although the Vascular Endothelial Growth Factor (VEGF) through gonadotropins guides [...] Read more.
The development of an adequate blood vessel network is crucial for the accomplishment of ovarian follicle growth and ovulation, which is necessary to support the proliferative and endocrine functions of the follicular cells. Although the Vascular Endothelial Growth Factor (VEGF) through gonadotropins guides ovarian angiogenesis, the role exerted by the switch on of Progesterone (P4) during the periovulatory phase remains to be clarified. The present research aimed to investigate in vivo VEGF-mediated mechanisms by inducing the development of periovulatory follicles using a pharmacologically validated synchronization treatment carried out in presence or absence of P4 receptor antagonist RU486. Spatio-temporal expression profiles of VEGF, FLT1, and FLK1 receptors and the two major MAPK/ERKs and PI3K/AKT downstream pathways were analyzed on granulosa and on theca compartment. For the first time, the results demonstrated that in vivo administration of P4 antagonist RU486 inhibits follicular VEGF receptors’ signaling mainly acting on the theca layer by downregulating the activation of ERKs and AKTs. Under the effect of RU486, periovulatory follicles’ microarchitecture did not move towards the periovulatory stage. The present evidence provides new insights on P4 in vivo biological effects in driving vascular and tissue remodeling during the periovulatory phase. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

22 pages, 3636 KiB  
Article
Equine Chorionic Gonadotropin as an Effective FSH Replacement for In Vitro Ovine Follicle and Oocyte Development
by Chiara Di Berardino, Alessia Peserico, Giulia Capacchietti, Martina Crociati, Maurizio Monaci, Umberto Tosi, Annunziata Mauro, Valentina Russo, Nicola Bernabò and Barbara Barboni
Int. J. Mol. Sci. 2021, 22(22), 12422; https://doi.org/10.3390/ijms222212422 - 17 Nov 2021
Cited by 6 | Viewed by 2423
Abstract
The use of assisted reproductive technologies (ART) still requires strategies through which to maximize individual fertility chances. In vitro folliculogenesis (ivF) may represent a valid option to convey the large source of immature oocytes in ART. Several efforts have been made [...] Read more.
The use of assisted reproductive technologies (ART) still requires strategies through which to maximize individual fertility chances. In vitro folliculogenesis (ivF) may represent a valid option to convey the large source of immature oocytes in ART. Several efforts have been made to set up ivF cultural protocols in medium-sized mammals, starting with the identification of the most suitable gonadotropic stimulus. In this study, Equine Chorionic Gonadotropin (eCG) is proposed as an alternative to Follicle Stimulating Hormone (FSH) based on its long superovulation use, trans-species validation, long half-life, and low costs. The use of 3D ivF on single-ovine preantral (PA) follicles allowed us to compare the hormonal effects and to validate their influence under two different cultural conditions. The use of eCG helped to stimulate the in vitro growth of ovine PA follicles by maximizing its influence under FBS-free medium. Higher performance of follicular growth, antrum formation, steroidogenic activity and gap junction marker expression were recorded. In addition, eCG, promoted a positive effect on the germinal compartment, leading to a higher incidence of meiotic competent oocytes. These findings should help to widen the use of eCG to ivF as a valid and largely available hormonal support enabling a synchronized in vitro follicle and oocyte development. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

19 pages, 2747 KiB  
Article
Ovarian Folliculogenesis and Uterine Endometrial Receptivity after Intermittent Vaginal Injection of Recombinant Human Follicle-Stimulating Hormone in Infertile Women Receiving In Vitro Fertilization and in Immature Female Rats
by Chao-Chin Hsu, Leonard Hsu, Yuan-Shuo Hsueh, Chih-Ying Lin, Hui Hua Chang and Chao-Tien Hsu
Int. J. Mol. Sci. 2021, 22(19), 10769; https://doi.org/10.3390/ijms221910769 - 05 Oct 2021
Cited by 5 | Viewed by 2265
Abstract
The uterine first-pass effect occurs when drugs are delivered vaginally. However, the effect of vaginally administered recombinant human follicle-stimulating hormone (rhFSH) on ovarian folliculogenesis and endometrial receptivity is not well established. We aimed to compare the efficacy of rhFSH administered vaginally and abdominally [...] Read more.
The uterine first-pass effect occurs when drugs are delivered vaginally. However, the effect of vaginally administered recombinant human follicle-stimulating hormone (rhFSH) on ovarian folliculogenesis and endometrial receptivity is not well established. We aimed to compare the efficacy of rhFSH administered vaginally and abdominally in clinical in vitro fertilization (IVF) treatment, pharmacokinetic study, and animal study. In IVF treatment, the number of oocytes retrieved, endometrial thickness and uterine artery blood perfusion were not different between women who received the rhFSH either vaginally or abdominally. For serum pharmacokinetic parameters, significantly lower Tmax, clearance, and higher AUC and T1/2_elimination of rhFSH were observed in women who received rhFSH vaginally, but urine parameters were not different. Immature female rats that received daily abdominal or vaginal injections (1 IU twice daily for 4 days) or intermittent vaginal injections (4 IU every other day for two doses) of rhFSH had more total follicles than the control group. In addition, the serum progesterone and progesterone receptors in the local endometrium were significantly higher in the groups treated with intermittent abdominal or vaginal injection of rhFSH, compared with those who recieved daily injection. In summary, vaginal administration of rhFSH may provide an alternative treatment regimen in women receiving IVF. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

23 pages, 4886 KiB  
Article
Pharmacological Characterization of Low Molecular Weight Biased Agonists at the Follicle Stimulating Hormone Receptor
by Francesco De Pascali, Mohammed Akli Ayoub, Riccardo Benevelli, Silvia Sposini, Jordan Lehoux, Nathalie Gallay, Pauline Raynaud, Flavie Landomiel, Frédéric Jean-Alphonse, Christophe Gauthier, Lucie P. Pellissier, Pascale Crépieux, Anne Poupon, Asuka Inoue, Nicolas Joubert, Marie-Claude Viaud-Massuard, Livio Casarini, Manuela Simoni, Aylin C. Hanyaloglu, Selva G. Nataraja, Henry N. Yu, Stephen S. Palmer, Romain Yvinec and Eric Reiteradd Show full author list remove Hide full author list
Int. J. Mol. Sci. 2021, 22(18), 9850; https://doi.org/10.3390/ijms22189850 - 12 Sep 2021
Cited by 6 | Viewed by 2999
Abstract
Follicle-stimulating hormone receptor (FSHR) plays a key role in reproduction through the activation of multiple signaling pathways. Low molecular weight (LMW) ligands composed of biased agonist properties are highly valuable tools to decipher complex signaling mechanisms as they allow selective activation of discrete [...] Read more.
Follicle-stimulating hormone receptor (FSHR) plays a key role in reproduction through the activation of multiple signaling pathways. Low molecular weight (LMW) ligands composed of biased agonist properties are highly valuable tools to decipher complex signaling mechanisms as they allow selective activation of discrete signaling cascades. However, available LMW FSHR ligands have not been fully characterized yet. In this context, we explored the pharmacological diversity of three benzamide and two thiazolidinone derivatives compared to FSH. Concentration/activity curves were generated for Gαs, Gαq, Gαi, β-arrestin 2 recruitment, and cAMP production, using BRET assays in living cells. ERK phosphorylation was analyzed by Western blotting, and CRE-dependent transcription was assessed using a luciferase reporter assay. All assays were done in either wild-type, Gαs or β-arrestin 1/2 CRISPR knockout HEK293 cells. Bias factors were calculated for each pair of read-outs by using the operational model. Our results show that each ligand presented a discrete pharmacological efficacy compared to FSH, ranging from super-agonist for β-arrestin 2 recruitment to pure Gαs bias. Interestingly, LMW ligands generated kinetic profiles distinct from FSH (i.e., faster, slower or transient, depending on the ligand) and correlated with CRE-dependent transcription. In addition, clear system biases were observed in cells depleted of either Gαs or β-arrestin genes. Such LMW properties are useful pharmacological tools to better dissect the multiple signaling pathways activated by FSHR and assess their relative contributions at the cellular and physio-pathological levels. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

Review

Jump to: Editorial, Research

11 pages, 1385 KiB  
Review
Aberrant Notch Signaling Pathway as a Potential Mechanism of Central Precocious Puberty
by Young Suk Shim, Hae Sang Lee and Jin Soon Hwang
Int. J. Mol. Sci. 2022, 23(6), 3332; https://doi.org/10.3390/ijms23063332 - 19 Mar 2022
Cited by 11 | Viewed by 2406
Abstract
The Notch signaling pathway is highly conserved during evolution. It has been well documented that Notch signaling regulates cell proliferation, migration, and death in the nervous, cardiac, and endocrine systems. The Notch pathway is relatively simple, but its activity is regulated by numerous [...] Read more.
The Notch signaling pathway is highly conserved during evolution. It has been well documented that Notch signaling regulates cell proliferation, migration, and death in the nervous, cardiac, and endocrine systems. The Notch pathway is relatively simple, but its activity is regulated by numerous complex mechanisms. Ligands bind to Notch receptors, inducing their activation and cleavage. Various post-translational processes regulate Notch signaling by affecting the synthesis, secretion, activation, and degradation of Notch pathway-related proteins. Through such post-translational regulatory processes, Notch signaling has versatile effects in many tissues, including the hypothalamus. Recently, several studies have reported that mutations in genes related to the Notch signaling pathway were found in patients with central precocious puberty (CPP). CPP is characterized by the early activation of the hypothalamus–pituitary–gonadal (HPG) axis. Although genetic factors play an important role in CPP development, few associated genetic variants have been identified. Aberrant Notch signaling may be associated with abnormal pubertal development. In this review, we discuss the current knowledge about the role of the Notch signaling pathway in puberty and consider the potential mechanisms underlying CPP. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

20 pages, 2418 KiB  
Review
ERβ Regulation of Gonadotropin Responses during Folliculogenesis
by Eun B. Lee, V. Praveen Chakravarthi, Michael W. Wolfe and M. A. Karim Rumi
Int. J. Mol. Sci. 2021, 22(19), 10348; https://doi.org/10.3390/ijms221910348 - 26 Sep 2021
Cited by 30 | Viewed by 7609
Abstract
Gonadotropins are essential for regulating ovarian development, steroidogenesis, and gametogenesis. While follicle stimulating hormone (FSH) promotes the development of ovarian follicles, luteinizing hormone (LH) regulates preovulatory maturation of oocytes, ovulation, and formation of corpus luteum. Cognate receptors of FSH and LH are G-protein [...] Read more.
Gonadotropins are essential for regulating ovarian development, steroidogenesis, and gametogenesis. While follicle stimulating hormone (FSH) promotes the development of ovarian follicles, luteinizing hormone (LH) regulates preovulatory maturation of oocytes, ovulation, and formation of corpus luteum. Cognate receptors of FSH and LH are G-protein coupled receptors that predominantly signal through cAMP-dependent and cAMP-independent mechanisms that activate protein kinases. Subsequent vital steps in response to gonadotropins are mediated through activation or inhibition of transcription factors required for follicular gene expression. Estrogen receptors, classical ligand-activated transcriptional regulators, play crucial roles in regulating gonadotropin secretion from the hypothalamic–pituitary axis as well as gonadotropin function in the target organs. In this review, we discuss the role of estrogen receptor β (ERβ) regulating gonadotropin response during folliculogenesis. Ovarian follicles in Erβ knockout (ErβKO) mutant female mice and rats cannot develop beyond the antral state, lack oocyte maturation, and fail to ovulate. Theca cells (TCs) in ovarian follicles express LH receptor, whereas granulosa cells (GCs) express both FSH receptor (FSHR) and LH receptor (LHCGR). As oocytes do not express the gonadotropin receptors, the somatic cells play a crucial role during gonadotropin induced oocyte maturation. Somatic cells also express high levels of estrogen receptors; while TCs express ERα and are involved in steroidogenesis, GCs express ERβ and are involved in both steroidogenesis and folliculogenesis. GCs are the primary site of ERβ-regulated gene expression. We observed that a subset of gonadotropin-induced genes in GCs, which are essential for ovarian follicle development, oocyte maturation and ovulation, are dependent on ERβ. Thus, ERβ plays a vital role in regulating the gonadotropin responses in ovary. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Figure 1

27 pages, 1708 KiB  
Review
Actions and Roles of FSH in Germinative Cells
by Kaiana Recchia, Amanda Soares Jorge, Laís Vicari de Figueiredo Pessôa, Ramon Cesar Botigelli, Vanessa Cristiane Zugaib, Aline Fernanda de Souza, Daniele dos Santos Martins, Carlos Eduardo Ambrósio, Fabiana Fernandes Bressan and Naira Caroline Godoy Pieri
Int. J. Mol. Sci. 2021, 22(18), 10110; https://doi.org/10.3390/ijms221810110 - 18 Sep 2021
Cited by 26 | Viewed by 7445
Abstract
Follicle stimulating hormone (FSH) is produced by the pituitary gland in a coordinated hypothalamic–pituitary–gonadal (HPG) axis event, plays important roles in reproduction and germ cell development during different phases of reproductive development (fetal, neonatal, puberty, and adult life), and is consequently essential for [...] Read more.
Follicle stimulating hormone (FSH) is produced by the pituitary gland in a coordinated hypothalamic–pituitary–gonadal (HPG) axis event, plays important roles in reproduction and germ cell development during different phases of reproductive development (fetal, neonatal, puberty, and adult life), and is consequently essential for fertility. FSH is a heterodimeric glycoprotein hormone of two dissociable subunits, α and β. The FSH β-subunit (FSHβ) function starts upon coupling to its specific receptor: follicle-stimulating hormone receptor (FSHR). FSHRs are localized mainly on the surface of target cells on the testis and ovary (granulosa and Sertoli cells) and have recently been found in testicular stem cells and extra-gonadal tissue. Several reproduction disorders are associated with absent or low FSH secretion, with mutation of the FSH β-subunit or the FSH receptor, and/or its signaling pathways. However, the influence of FSH on germ cells is still poorly understood; some studies have suggested that this hormone also plays a determinant role in the self-renewal of germinative cells and acts to increase undifferentiated spermatogonia proliferation. In addition, in vitro, together with other factors, it assists the process of differentiation of primordial germ cells (PGCLCs) into gametes (oocyte-like and SSCLCs). In this review, we describe relevant research on the influence of FSH on spermatogenesis and folliculogenesis, mainly in the germ cell of humans and other species. The possible roles of FSH in germ cell generation in vitro are also presented. Full article
(This article belongs to the Special Issue Gonadotropin Cell Transduction Mechanisms)
Show Figures

Graphical abstract

Back to TopTop